CRDA:LSE-Croda International Plc (GBX)

COMMON STOCK | Specialty Chemicals | LSE

Last Closing Price

GBX 8,534.00

Change

+110.00 (+1.31)%

Market Cap

GBX 11.75B

Volume

0.38M

Avg Analyst Target

GBX 9,350.00 (+9.56%)

Avg User Target

GBX
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Croda International Plc (CRDA) Stock Analysis:
Based on the Croda International Plc stock forecasts from 5 analysts, the average analyst target price for Croda International Plc is GBX 9,350.00 over the next 12 months. Croda International Plc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Croda International Plc is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Croda International Plc’s stock price was GBX 8,534.00. Croda International Plc’s stock price has changed by -500.00% over the past week, -1,388.00% over the past month and +34.56% over the last year.

About

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adh ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-17 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
0QJS:LSE Clariant AG

N/A

GBX6.36B 7.72 N/A
JMAT:LSE Johnson Matthey Plc

-15.00 (-0.76%)

GBX3.76B 24.84 8.98
VCT:LSE Victrex plc

-4.00 (-0.17%)

GBX2.00B 27.36 18.29
SYNT:LSE Synthomer plc

+0.80 (+0.21%)

GBX1.61B 7.46 5.93
ESNT:LSE Essentra plc

+2.50 (+0.71%)

GBX1.06B 56.69 10.64
ELM:LSE Elementis plc

-1.50 (-1.10%)

GBX0.79B 97.29 9.82
TET:LSE Treatt plc

+20.00 (+1.63%)

GBX0.73B 49.20 33.92
SCPA:LSE Scapa Group plc

N/A

GBX0.40B 471.50 12.46
ZTF:LSE Zotefoams plc

+2.00 (+0.50%)

GBX0.19B 23.98 13.93
DCTA:LSE Directa Plus Plc

+0.50 (+0.34%)

GBX0.10B N/A N/A

ETFs Containing CRDA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.67% 6% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.67% 6% F 3% F
Trailing 12 Months  
Capital Gain 34.56% 87% B+ 86% B
Dividend Return 0.01% 14% F 17% F
Total Return 34.58% 87% B+ 86% B
Trailing 5 Years  
Capital Gain 150.55% 87% B+ 93% A
Dividend Return 11.51% 75% C 54% F
Total Return 162.06% 87% B+ 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.37% 67% D+ 78% C+
Dividend Return 1.92% 50% F 59% F
Total Return 22.28% 67% D+ 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 19.31% 93% A 59% F
Risk Adjusted Return 115.38% 100% A+ 95% A
Market Capitalization 11.75B 100% A+ 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 46.31 36% F 16% F
Price/Book Ratio 8.79 20% F 8% F
Price / Cash Flow Ratio 40.95 13% F 10% F
EV/EBITDA 33.99 11% F 15% F
Management Effectiveness  
Return on Equity 18.69% 93% A 72% C-
Return on Invested Capital 11.51% 67% D+ 80% B-
Return on Assets 8.85% 81% B- 79% C+
Debt to Equity Ratio 48.95% 31% F 32% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.48 100% A+ 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector